Log In
BCIQ
Print this Print this
 

isotretinoin (PAT-001)

  Manage Alerts
Collapse Summary General Information
Company Patagonia Pharmaceuticals LLC
DescriptionSynthetic vitamin A analog
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationIchthyosis
Indication DetailsTreat congenital ichthyosis
Regulatory Designation U.S. - Orphan Drug (Treat congenital ichthyosis)
PartnerAlmirall S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$3.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/22/2016

Undisclosed

$3.5M

Undisclosed

Get a free BioCentury trial today